Table 2.
Sample no. | FSHR 307 CADMA | FSHR 680 CADMA | FSHR 307 AS-PCR | FSHR 680 AS-PCR | FSHR 307 Sequencing | FSHR 680 Sequencing | |
---|---|---|---|---|---|---|---|
High quality DNA | 1 | TT | TT | TT | CT | TT | TT |
2 | TT | TT | TT | TT | TT | TT | |
3 | TT | TT | TT | TT | TT | – | |
4 | TT | TT | TT | TT | – | TT | |
5 | TT | TT | TT | TT | TT | TT | |
6 | TT | TT | TT | TT | poor quality | TT | |
7 | CT | CT | CT | CT | CT | – | |
8 | CT | CT | CT | CT | CT | CT | |
9 | CT | CT | CT | CT | – | CT | |
10 | CT | CT | CT | CT | CT | CT | |
11 | CT | CT | CT | TT | CT | CT | |
12 | CT | CT | CT | CT | CT | CT | |
13 | CC | CC | CC | CC | CC | CC | |
14 | CC | CC | CC | CC | CC | CC | |
15 | CC | CC | CC | CC | – | CC | |
16 | CC | CC | CC | CC | CC | – | |
17 | CC | CC | CC | CC | CC | CC | |
18 | CC | CC | no amplification | no amplification | CC | CC | |
Trizol DNA | 19 | TT | TT | TT* | – | TT | TT |
20 | TT | TT | TT* | – | poor quality | poor quality | |
21 | CT | CT | CT*† | – | poor quality | poor quality | |
22 | CT | CT | – | – | poor quality | CT | |
23 | CC | CC | CC* | – | CC | CC | |
24 | CC | CC | no amplification* | – | poor quality | poor quality |
Discrepancies between assays are highlighted in red
-As sample material was limited, some of the samples could not be tested for all six genotyping assays
*The AS-PCR was performed with an additional + 6 cycles, in order to achieve results for comparison
†The AS-PCR had to be re-run in order to achieve results for comparison